Originally posted by pat
View Post
The test you refer to is VERY limited and only covers a small subset of patients. It's not the panacea many think it is from what I've read. How fast it gets on the market is really irrelevant to most because it they aren't candidates *anyway*.
It's a start, but it's overrated in its current form.
Comment